pharmaceutical daily

Advanced Oncotherapy names CERN’s Stephen Myers new Chairman of ADAM

Advanced Oncotherapy, the developer of proton therapy systems for cancer treatment, has appointed Professor Stephen Myers OBE, Head of Medical Applications at CERN, as Executive Chairman of its fully owned subsidiary ADAM S.A.

stephen myers

Stephen Myers

ADAM was founded in 2007 as a spin-off from CERN, the European Organisation for Nuclear Research, and was acquired by Advanced Oncotherapy in 2013. The ADAM team is responsible for designing and developing Advanced Oncotherapy ‘s proton beam cancer therapy technology, the LIGHT system.

Sanjeev Pandya, CEO of Advanced Oncotherapy noted that Professor Myers has been part of the CERN Scientific Review Board since its inception in January 2015 and has provided the company with invaluable advice and high level guidance during this time.

“We are extremely lucky to have someone of his calibre on board and we are looking forward to working more closely with Steve in the future,” added Pandya.

Exit mobile version